Mutated acvr1 for diagnosis and treatment of fibrodyplasia...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/16 (2006.01) A01K 67/027 (2006.01) A61K 31/7088 (2006.01) A61K 31/7105 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C07K 14/72 (2006.01) C07K 16/28 (2006.01) C12N 15/12 (2006.01) C12P 19/34 (2006.01) C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/563 (2006.01) G01N 33/566 (2006.01) G01N 33/58 (2006.01)

Patent

CA 2649770

This invention is directed to mutated Activin A type I receptor proteins (ACVR1) and isolated nucleic acids encoding same. The invention also relates to the use of mutated ACVR1 in the diagnosis and treatment of Fibrodysplasia Ossificans Progressiva (FOP).

L'invention concerne des protéines mutantes du récepteur de l'activine A de type I (ACVR1) et des acides nucléiques isolés codant pour ce récepteur. L'invention se rapporte également à l'utilisation de ces ACVR1 mutants pour le diagnostic et le traitement de la fibrodysplasie ossifiante progressive (FOP).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutated acvr1 for diagnosis and treatment of fibrodyplasia... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutated acvr1 for diagnosis and treatment of fibrodyplasia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutated acvr1 for diagnosis and treatment of fibrodyplasia... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1469856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.